Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Uncategorized
CME Updates on Metastatic Pancreatic Cancer Guidelines Live Webinar Series…
Metastatic pancreatic cancer is a serious malignancy that, with limited treatment options and poor outcomes, poses a growing…
FDA-Duke to Host Public Workshop Focused on Key Competencies for Opioid…
Duke-Margolis Center for Public Policy and the Food and Drug Administration (FDA) are hosting a virtual workshop on April 4th and…
Patients and Advocates Frustrated by CMS Draft Decision Regarding Aduhelm
In early January 2022, the Centers for Medicare and Medicaid (CMS) released a draft decision that would only permit Medicare…
Policy and Medicine Compliance Update January 2021 Issue Offers insights…
Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go…
FDA Issues Notice on Implementation of Genus Decision
In early August 2021, the United States Food and Drug Administration (FDA) posted a Notice in the Federal Register about its…
Policy and Medicine Compliance Update — September 2021 Issue Reviews…
Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…
August 2021 Issue P&M Compliance Update features interview with…
Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…
Medicare Hospital Inpatient Proposed Payment Rule Calls for Additional…
The Centers for Medicare & Medicaid Services (CMS) released its annual proposal for the Hospital Inpatient Prospective Payment…
CMS Suspends Advance Payment Program
The Centers for Medicare & Medicaid Services (CMS) announced that it has suspended its Advance Payment Program to Part B…
FDA OPDP Issues Warning Letter to Metuchen Pharma About ED Drug Advertising
Recently, the US Food and Drug Administration Office of Prescription Drug Promotion (“OPDP”) sent a warning letter to Metuchen…